New award evaluation of the cell and gene therapy access model 75FCMC19D0080/75FCMC24F0135

Active Awarded Last action

Contract number
75FCMC24F0164
Awardee
Awarding agency
Obligated
$6,387,451

Award facts

Contract value 41% obligated
  • $6,387,451.00 Current, with exercised options
  • $15,537,334.00 Potential, with all options
Completion date 28% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 3 offers Multiple Award, Fair Opportunity
Pricing
Cost Plus Fixed Fee
Place of performance
Windsor Mill, Milford Mill, MD 21244, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00004 · Evaluation of the cell and gene therapy access model $0
Other Administrative Action P00003 · Evaluation of the cell and gene therapy access model. Incorporate far 52.222-90 addressing DEI discrimination by federal contractors (april 2026) to comply with… $0
Other Administrative Action P00002 · EOI::EO: radical transparency about wasteful spending::EOI bilateral modification to descope per executive order 14222, implementing the presidents department… -$1,499,325
Other Administrative Action P00001 $0
Original award $7,886,776

About this award

The Centers for Medicare and Medicaid Services issued a delivery order to ABT Global LLC on August 16, 2024, under the Research, Measurement, Assessment, Design, and Analysis 2 (RMADA 2) IDIQ for evaluation of the cell and gene therapy access model, with a ceiling value of $15.5 million.

RMADA 2 is a multiple-award IDIQ supporting research, measurement, assessment, design, and analysis services across CMS. Place of performance is Windsor Mill and Milford Mill, MD. The order runs through August 15, 2032, under a cost-plus-fixed-fee pricing structure with no set-aside.

In FY2025, the order invoiced $2.2 million against 4.8 FTEs, with the prime self-performing all reported hours.

Quick answers

Who was awarded contract 75FCMC24F0164?

75FCMC24F0164 was awarded to ABT Global LLC by Centers for Medicare and Medicaid Services (Department of Health and Human Services) on August 16, 2024.

How much is contract 75FCMC24F0164 worth?

The government has obligated $6,387,451 on 75FCMC24F0164. Its potential value, with all options, is $15,537,334.

Is contract 75FCMC24F0164 an order under another contract?

Yes. 75FCMC24F0164 is a delivery order under 75FCMC19D0080, an indefinite delivery contract, on Research, Measurement, Assessment, Design, and Analysis 2 (RMADA 2).

Was contract 75FCMC24F0164 competed?

The extent of competition for 75FCMC24F0164 was full and open competition. The government received 3 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award